Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Epidermal stem cells are vital for skin healing and have potential for treating skin disorders.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Skin cells show flexibility in healing wounds and forming tumors, with potential for treating hair disorders and chronic ulcers.

Advancements in wound healing aim to improve personalized treatments and enhance healing outcomes.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Blocking interferon-gamma might help treat various autoimmune diseases.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Targeting CXCL10 may help treat alopecia areata.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

FilaggrinHigh melanomas have active FGFR signaling and weak GNA14 and Th1 signatures.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Gushen Shengfa pills and Wuling capsules are more effective for hair growth and sleep quality than the control treatment.

A vitamin D receptor mutation causes rickets and affects immune responses.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.